259 related articles for article (PubMed ID: 31492175)
1. Deciphering DNA methylation signatures of pancreatic cancer and pancreatitis.
Natale F; Vivo M; Falco G; Angrisano T
Clin Epigenetics; 2019 Sep; 11(1):132. PubMed ID: 31492175
[TBL] [Abstract][Full Text] [Related]
2. Cell-Free DNA Methylation: The New Frontiers of Pancreatic Cancer Biomarkers' Discovery.
Brancaccio M; Natale F; Falco G; Angrisano T
Genes (Basel); 2019 Dec; 11(1):. PubMed ID: 31877923
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide DNA methylation analysis reveals molecular subtypes of pancreatic cancer.
Mishra NK; Guda C
Oncotarget; 2017 Apr; 8(17):28990-29012. PubMed ID: 28423671
[TBL] [Abstract][Full Text] [Related]
4. Preliminary study analyzing the methylated genes in the plasma of patients with pancreatic cancer.
Park JW; Baek IH; Kim YT
Scand J Surg; 2012; 101(1):38-44. PubMed ID: 22414467
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease.
Matsubayashi H; Canto M; Sato N; Klein A; Abe T; Yamashita K; Yeo CJ; Kalloo A; Hruban R; Goggins M
Cancer Res; 2006 Jan; 66(2):1208-17. PubMed ID: 16424060
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic cancer patient survival correlates with DNA methylation of pancreas development genes.
Thompson MJ; Rubbi L; Dawson DW; Donahue TR; Pellegrini M
PLoS One; 2015; 10(6):e0128814. PubMed ID: 26039411
[TBL] [Abstract][Full Text] [Related]
7. Cell-free DNA promoter hypermethylation in plasma as a diagnostic marker for pancreatic adenocarcinoma.
Henriksen SD; Madsen PH; Larsen AC; Johansen MB; Drewes AM; Pedersen IS; Krarup H; Thorlacius-Ussing O
Clin Epigenetics; 2016; 8():117. PubMed ID: 27891190
[TBL] [Abstract][Full Text] [Related]
8. Differential methylation of cell-free circulating DNA among patients with pancreatic cancer versus chronic pancreatitis.
Liggett T; Melnikov A; Yi QL; Replogle C; Brand R; Kaul K; Talamonti M; Abrams RA; Levenson V
Cancer; 2010 Apr; 116(7):1674-80. PubMed ID: 20143430
[TBL] [Abstract][Full Text] [Related]
9. Age- and disease-related methylation of multiple genes in nonneoplastic duodenum and in duodenal juice.
Matsubayashi H; Sato N; Brune K; Blackford AL; Hruban RH; Canto M; Yeo CJ; Goggins M
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):573-83. PubMed ID: 15701843
[TBL] [Abstract][Full Text] [Related]
10. p16(INK4a) alterations in chronic pancreatitis-indicator for high-risk lesions for pancreatic cancer.
Gerdes B; Ramaswamy A; Kersting M; Ernst M; Lang S; Schuermann M; Wild A; Bartsch DK
Surgery; 2001 Apr; 129(4):490-7. PubMed ID: 11283541
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of chronic pancreatitis from pancreatic cancer: recent advances in molecular diagnosis.
Ebert M; Schandl L; Schmid RM
Dig Dis; 2001; 19(1):32-6. PubMed ID: 11385249
[TBL] [Abstract][Full Text] [Related]
12. The role of quantitative NPTX2 hypermethylation as a novel serum diagnostic marker in pancreatic cancer.
Park JK; Ryu JK; Yoon WJ; Lee SH; Lee GY; Jeong KS; Kim YT; Yoon YB
Pancreas; 2012 Jan; 41(1):95-101. PubMed ID: 21778928
[TBL] [Abstract][Full Text] [Related]
13. Molecular analysis to detect pancreatic ductal adenocarcinoma in high-risk groups.
Yan L; McFaul C; Howes N; Leslie J; Lancaster G; Wong T; Threadgold J; Evans J; Gilmore I; Smart H; Lombard M; Neoptolemos J; Greenhalf W
Gastroenterology; 2005 Jun; 128(7):2124-30. PubMed ID: 15940643
[TBL] [Abstract][Full Text] [Related]
14. High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinoma.
Curia MC; Fantini F; Lattanzio R; Tavano F; Di Mola F; Piantelli M; Battista P; Di Sebastiano P; Cama A
BMC Cancer; 2019 May; 19(1):452. PubMed ID: 31088413
[TBL] [Abstract][Full Text] [Related]
15. Recent patents concerning diagnostic and therapeutic applications of aberrantly methylated sequences in pancreatic cancer.
Wehrum D; Grützmann R; Hennig M; Saeger HD; Pilarsky C
Recent Pat DNA Gene Seq; 2008; 2(2):97-106. PubMed ID: 19075949
[TBL] [Abstract][Full Text] [Related]
16. Early epigenetic downregulation of WNK2 kinase during pancreatic ductal adenocarcinoma development.
Dutruel C; Bergmann F; Rooman I; Zucknick M; Weichenhan D; Geiselhart L; Kaffenberger T; Rachakonda PS; Bauer A; Giese N; Hong C; Xie H; Costello JF; Hoheisel J; Kumar R; Rehli M; Schirmacher P; Werner J; Plass C; Popanda O; Schmezer P
Oncogene; 2014 Jun; 33(26):3401-10. PubMed ID: 23912455
[TBL] [Abstract][Full Text] [Related]
17. Identification of 27 5' CpG islands aberrantly methylated and 13 genes silenced in human pancreatic cancers.
Hagihara A; Miyamoto K; Furuta J; Hiraoka N; Wakazono K; Seki S; Fukushima S; Tsao MS; Sugimura T; Ushijima T
Oncogene; 2004 Nov; 23(53):8705-10. PubMed ID: 15467763
[TBL] [Abstract][Full Text] [Related]
18. The role of epigenetic alterations in pancreatic cancer.
Sato N; Goggins M
J Hepatobiliary Pancreat Surg; 2006; 13(4):286-95. PubMed ID: 16858539
[TBL] [Abstract][Full Text] [Related]
19. Genetic and epigenetic markers in the evaluation of pancreatic masses.
Ginestà MM; Mora J; Mayor R; Farré A; Peinado MA; Busquets J; Serrano T; Capellá G; Fabregat J
J Clin Pathol; 2013 Mar; 66(3):192-7. PubMed ID: 23135349
[TBL] [Abstract][Full Text] [Related]
20. Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer.
Logsdon CD; Simeone DM; Binkley C; Arumugam T; Greenson JK; Giordano TJ; Misek DE; Kuick R; Hanash S
Cancer Res; 2003 May; 63(10):2649-57. PubMed ID: 12750293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
